MSB 1.34% $1.51 mesoblast limited

CHF - MSB's Dark Horse with Multi-billion dollar potential, page-407

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    "I have said all along that IMO the CHF partner has already been agreed upon on a what if basis pending the FDA guidance decision... this far down the track you would certainly hope so anyway .... just who that big pharma is though remains a mysteryclear.png"

    So, is this why they announced the Novartis deal with certain conditions pending on ARDs.
    yet now, you are suggesting they are holding back information about a "big pharma" deal that has been "agreed upon" for CHF.

    LOL....new week, let's roll out that Col smoke blaster one more time


    Last edited by Sector: 18/07/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.